Shanghai Total Liab from 2010 to 2024

688217 Stock   21.07  0.83  3.79%   
Shanghai Rightongene's Total Liabilities is increasing over the years with slightly volatile fluctuation. Overall, Total Liabilities is expected to go to about 76.7 M this year. Total Liabilities is the total amount of all liabilities that Shanghai Rightongene Biotechnology has, including both short-term and long-term liabilities. View All Fundamentals
 
Total Liabilities  
First Reported
2010-12-31
Previous Quarter
76.5 M
Current Value
76.7 M
Quarterly Volatility
18.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Shanghai Rightongene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Shanghai Rightongene's main balance sheet or income statement drivers, such as Net Interest Income of 2.2 M, Interest Income of 2.8 M or Interest Expense of 464.7 K, as well as many indicators such as . Shanghai financial statements analysis is a perfect complement when working with Shanghai Rightongene Valuation or Volatility modules.
  
This module can also supplement various Shanghai Rightongene Technical models . Check out the analysis of Shanghai Rightongene Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Shanghai Stock

Shanghai Rightongene financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Rightongene security.